A new study provides strong evidence that the experimental drug given to two American aid workers stricken with Ebola in Africa really works and could make a difference in the current outbreak -- if more of it could be produced. In the study, all 18 monkeys exposed to a lethal dose of Ebola virus survived when given the drug, known as ZMapp, even when the treatment was started five days after infection, when the animals were already sick. "To actually be able to reverse all those symptoms and signs and bring them back to baseline, I think that is pretty astounding," said Dr. Kartik Chandran, an Ebola expert at the Albert Einstein College of Medicine who was not involved in the study.
Comments
Post a Comment